2019Journal of Investigative DermatologyOpen access

Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance

Rosie M. Butler, Robert C. McKenzie, Christine L. Jones, Charlotte E. Flanagan, Wesley J. Woollard, Maria Antonietta Demontis, Silvia Ferreira, Isabella Tosi, Susan John, Sean Whittaker, Tracey J. Mitchell

Open full text 11 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Romidepsin, Vorinostat, Histone deacetylase inhibitor, Histone deacetylase, Cancer research, Depsipeptide, Biology, Gene knockdown

Related papers

Back to paper searchBrowse research topicsOriginal source
Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance — Research Paper | ScholarLens